EZH2 and hepatocellular carcinoma: This result was consistent with the observation that up-regulated EZH2 expression is frequently detected (42%) among hepatocellular carcinoma cells (HCC) and that their growth rate was reduced in small interfering (siRNA)-mediated EZH2 knockdown experiments.